[The effect of hexabendin on oxygen consumption, energeties and substrate metabolism of the heart. II. Studies with intravenous infusions].
D000818:Animals; D001794:Blood Pressure; D003331:Coronary Vessels; D004285:Dogs; D004562:Electrocardiography; D004735:Energy Transfer; D005029:Ethylenediamines / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005947:Glucose / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate; D007263:Infusions, Parenteral; D007773:Lactates / Q000032:analysis / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D005029:Ethylenediamines; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D014665:Vasodilator Agents; D005947:Glucose
Die Wirkung von Hexobendin auf Sauerstoffverbrauch, Energetik und Substratstoffwechsel des Herzens. II. Versuche mit intravenösen Infusionen.